(Q46693823)

English

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

1 reference

based on heuristic

inferred from title

author name string

Ivanov V

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Faucher C

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Mohty M

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Bilger K

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Ladaique P

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Sainty D

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Arnoulet C

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Chabannon C

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Vey N

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Camerlo J

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Bouabdallah R

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Viens P

12

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Maraninchi D

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Bardou VJ

14

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Esterni B

15

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Blaise D

16

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

36

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

901-906

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

Erythropoietin in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Epoetin in cancer-related anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Recombinant human erythropoietin in the treatment of anemic patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Pure red-cell aplasia and epoetin therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

21 January 2018

Non-myeloablative transplants for malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705152

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705152

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16151421

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46693823&oldid=2217604966"